Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMälardalen University
About this trial
Summary
Reducing sedentary behavior during treatment is important to reduce the risk of future health problems in individuals undergoing cancer treatment. Therefore, the goal of this project is with a multicenter randomised controlled design investigate whether a digital support intervention during ongoing neo- or adjuvant cancer treatment for breast, prostate or colon cancer is effective in reducing sedentary lifestyle and improving well-being in the short and long term.
Eligibility criteria
Qualifiers
Individuals diagnosed with breast, prostate, or colorectal cancer planned for or resently started neo- or adjuvant treatment (e.g. chemotherapy, radiotherapy, endocrine treatment) at the hospitals in Uppsala and Västerås, Sweden.
Disqualifiers
Individuals diagnosed with dementia.
Individuals diagnosed with severe psychiatric disease.
Individuals with severe loss of vision, or communicative ability.
Individuals who cannot walk independently indoors with or without a walking aid.
Trial design
Treatments tested in this trial
- Digital self-management program
Treatment groups
172 Participants
are divided into 2 treatment groupsLocations
2Akademiska sjukhuset Uppsala Sweden
Västmanlands sjukhus Västerås Sweden
Sponsors and collaborators
Mälardalen University
Lead sponsor
Region Västmanland
Collaborator
Uppsala University
Collaborator
Centrallasarettet Västerås
Collaborator
Uppsala University Hospital
Collaborator
Uppsala County Council, Sweden
Collaborator
Source ClinicalTrials.gov